[CytoReason in The Times of Israel] Swiss pharma firm Ferring, Israel’s CytoReason join to battle bowel disease
CytoReason, an Israeli startup that uses artificial intelligence to build digital models of the human immune system and diseases to ...
CytoReason, an Israeli startup that uses artificial intelligence to build digital models of the human immune system and diseases to ...
Israeli startup CytoReason today announced a partnership with Swiss multinational, Ferring Pharmaceuticals, to establish new treatments for inflammatory bowel disease ...
TEL AVIV, Israel, May 19, 2021 /PRNewswire/ — CytoReason, an Israeli company developing a computational model of the human body ...
Copyright © 2021 198 Crowdfunding News.